| 1 |
33406639 | Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. | 2021 Jan 4 |
5 |
| 2 |
32350909 | Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activation. | 2020 Sep |
2 |
| 3 |
30487243 | Targeted Therapy for EBV-Associated B-cell Neoplasms. | 2019 Apr |
1 |
| 4 |
29699990 | TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia. | 2018 Jun 21 |
1 |